Beta-blocker interruption or continuation after myocardial infarction
Posted 19 Sept 2025
Dr Roger Henderson summarises findings from the ABYSS study, which assessed safety and quality of life following beta-blocker interruption versus continuation among patients with a history of myocardial infarction.
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.